Jennifer A. Fox

Chief Financial Officer, Nuvation Bio Inc.

Companies

Zenas BioPharma, Inc.Officer Sep 12, 2024 to now¹
Apogee Therapeutics, Inc.Board member Jul 13, 2023 to now²
PROKIDNEY CORP.Board member Jul 13, 2022 to now³
Nuvation Bio Inc.Chief financial officer Feb 12, 2021 to Mar 2, 2023⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Zenas BioPharma, Inc. ZBIO1,592 shares⁵$42.5K at $26.72Feb 5, 2026
Nuvation Bio Inc. NUVB4,481 shares⁶$19.9K at $4.45Mar 2, 2023
PROKIDNEY CORP. PROK0 shares⁷Jul 13, 2022
Apogee Therapeutics, Inc.0 shares⁸Sep 3, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 3, 2026Returned to company 34,824 shares of Apogee Therapeutics, Inc.⁸
Feb 5, 2026Granted 1,592 shares at $13.35 of Zenas BioPharma, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARZenas BioPharma, Inc., Officer
2
SEC EDGARApogee Therapeutics, Inc., Board member
3
SEC EDGARPROKIDNEY CORP., Board member
4
SEC EDGARNuvation Bio Inc., Chief financial officer
5
SEC EDGARZenas BioPharma, Inc. shares after the filing of Feb 5, 2026
6
SEC EDGARNuvation Bio Inc. shares after the filing of Mar 2, 2023
7
SEC EDGARPROKIDNEY CORP. shares after the filing of Jul 13, 2022
8
SEC EDGARApogee Therapeutics, Inc. shares after the filing of Sep 3, 2026